Edwards Lifesciences (EW) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.34% |
| Dec 31, 2025 | 5.88% |
| Sep 30, 2025 | -46.72% |
| Jun 30, 2025 | -6.98% |
| Mar 31, 2025 | 17.18% |
| Dec 31, 2024 | -162.70% |
| Sep 30, 2024 | 35.24% |
| Jun 30, 2024 | 79.42% |
| Mar 31, 2024 | 85.23% |
| Dec 31, 2023 | 13.63% |
| Sep 30, 2023 | 62.63% |
| Jun 30, 2023 | 104.12% |
| Mar 31, 2023 | -23.51% |
| Dec 31, 2022 | -35.11% |
| Sep 30, 2022 | -20.55% |
| Jun 30, 2022 | 20.02% |
| Mar 31, 2022 | 27.61% |
| Dec 31, 2021 | -33.78% |
| Sep 30, 2021 | -6.69% |
| Jun 30, 2021 | 25.68% |
| Mar 31, 2021 | 35.75% |
| Dec 31, 2020 | 20.49% |
| Sep 30, 2020 | 19.64% |
| Jun 30, 2020 | 13.19% |
| Mar 31, 2020 | -23.50% |
| Dec 31, 2019 | -15.12% |
| Sep 30, 2019 | 47.10% |
| Jun 30, 2019 | -36.23% |
| Mar 31, 2019 | 50.79% |
| Dec 31, 2018 | -58.21% |
| Sep 30, 2018 | -19.74% |
| Jun 30, 2018 | 16.31% |
| Mar 31, 2018 | 35.62% |
| Dec 31, 2017 | 109.52% |
| Sep 30, 2017 | 157.20% |
| Jun 30, 2017 | -38.89% |
| Mar 31, 2017 | -39.23% |
| Dec 31, 2016 | 43.95% |
| Sep 30, 2016 | 30.07% |
| Jun 30, 2016 | 4.79% |
| Mar 31, 2016 | -20.73% |
| Dec 31, 2015 | 10.02% |
| Sep 30, 2015 | 15.47% |
| Jun 30, 2015 | 50.67% |
| Mar 31, 2015 | -347.32% |
| Dec 31, 2014 | 36.04% |
| Sep 30, 2014 | -24.18% |